Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.
1
公式I的化合物是丙型肝炎病毒(HCV)RNA依赖性RNA聚合酶(RdRp)
抑制剂,可用于治疗和预防感染丙型肝炎病毒的人。